Neurogene's total assets for Q2 2025 were $297.32M, a decrease of -5.70% from the previous quarter. NGNE total liabilities were $24.06M for the fiscal quarter, a 2.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.